BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6480307)

  • 1. Dynamic CT of liver cirrhosis.
    Partanen KP
    Invest Radiol; 1984; 19(4):303-8. PubMed ID: 6480307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast enhancement of the upper abdomen: effect of contrast medium and body weight.
    Kormano M; Partanen K; Soimakallio S; Kivimäki T
    Invest Radiol; 1983; 18(4):364-7. PubMed ID: 6618827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical comparison of Hexabrix, iopamidol, and Urografin-60 in whole body computed tomography.
    Spataro RF; Fischer HW; Kormano M
    Invest Radiol; 1984; 19(6 Suppl):S372-5. PubMed ID: 6511276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of diatrizoate, iopamidol, and ioxaglate for the contrast enhancement of experimental hepatic tumors in CT.
    Burgener FA; Steinmetz SD
    Invest Radiol; 1985 Sep; 20(6):626-31. PubMed ID: 4066232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced CT of the liver and spleen: comparison of ionic and nonionic contrast agents.
    Nelson RC; Chezmar JL; Peterson JE; Bernardino ME
    AJR Am J Roentgenol; 1989 Nov; 153(5):973-6. PubMed ID: 2801447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT-determined canine kidney and urine iodine concentration following intravenous administration of sodium diatrizoate, metrizamide, iopamidol, and sodium ioxaglate.
    Brennan RE; Rapoport S; Weinberg I; Pollack HM; Curtis JA
    Invest Radiol; 1982; 17(1):95-100. PubMed ID: 7076442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic CT of hepatic cirrhosis.
    Drop A; Rosińska-Bogusiewicz K; Zbańska-Klonowska K; Czekajska-Chehab E
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):39-46. PubMed ID: 12898816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of diatrizoate, iopamidol, and ioxaglate for arterial portography. An experimental study in normal dogs and dogs with portal hypertension.
    Burgener FA; Gutierrez OH
    Invest Radiol; 1985 Jul; 20(4):399-402. PubMed ID: 4044182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excretion of urographic contrast media. I. Iohexol and other media during free urine flow in the rabbit.
    Sjöberg S; Almén T; Golman K
    Acta Radiol Suppl; 1980; 362():93-8. PubMed ID: 6267900
    [No Abstract]   [Full Text] [Related]  

  • 10. Urography with low-osmolality contrast media: comparative urinary excretion of Iopamidol, Hexabrix, and diatrizoate.
    Spataro RF; Fischer HW; Boylan L
    Invest Radiol; 1982; 17(5):494-500. PubMed ID: 7141831
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adverse reactions following high-dose intravenous injection of urographic contrast media].
    Lackner K; Köster O; von Uexküll V; Broich H
    Rofo; 1984 Oct; 141(4):447-52. PubMed ID: 6436920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low osmolality contrast media in peripheral arteriography--clinical comparison of ioxaglate, iopamidol, iohexol and diatrizoate].
    Tajima H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Nov; 45(11):1407-20. PubMed ID: 4094879
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of hepatic density change by dynamic CT in healthy humans and in patients with chronic liver diseases.
    Sugano S; Okajima T; Kubo S; Yamazaki Y; Sumino Y; Abei T
    Dig Dis Sci; 1992 Feb; 37(2):220-4. PubMed ID: 1735339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative effects on left ventricular function in coronary patients of various contrast media used in coronarography: iopamidol, diatrizoate, ioxaglate].
    Crochet D; Petitier H; de Laguerenne J; Wanlin P; Bourdon A; Grossetête R
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):758-63. PubMed ID: 6670837
    [No Abstract]   [Full Text] [Related]  

  • 15. Contrast enhancement pharmacokinetics of six ionic and nonionic contrast media.
    Dean PB; Kivisaari L; Kormano M
    Invest Radiol; 1983; 18(4):368-74. PubMed ID: 6618828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of echogenic lesion of focal fatty infiltration in fibrotic liver.
    Nagoshi S; Sato Y; Fujiwara K
    Radiat Med; 1991; 9(3):91-4. PubMed ID: 1924846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing.
    Mitsuzaki K; Yamashita Y; Ogata I; Nishiharu T; Urata J; Takahashi M
    AJR Am J Roentgenol; 1996 Sep; 167(3):753-7. PubMed ID: 8751695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the side effects of urographic contrast media (iothalamate, diatrizoate, iodamide, iopamidol) within the scope of a CT study].
    Stellamor K; Hruby W; Assinger S; Luckner H
    Radiologe; 1984 Oct; 24(10):488-90. PubMed ID: 6505221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of iohexol and metrizamide in dynamic CT of the upper abdomen.
    Partanen K; Kormano M; Kivimäki T; Soimakallio S
    Eur J Radiol; 1984 Aug; 4(3):227-8. PubMed ID: 6468419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast bolus dynamic computed tomography for the measurement of solid organ perfusion.
    Blomley MJ; Coulden R; Bufkin C; Lipton MJ; Dawson P
    Invest Radiol; 1993 Nov; 28 Suppl 5():S72-7; discussion S78. PubMed ID: 8282508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.